cox--derived prostacyclin confers atheroprotection female mice 
female gender affords relative protection cardiovascular disease menopause report estrogen acts estrogen receptor subtype alpha up-regulate production atheroprotective prostacyclin pgi2 activation cyclooxygenase cox- mechanism restrained oxidant stress platelet activation contribute atherogenesis female mice deletion pgi2 receptor removed atheroprotective effect estrogen ovariectomized female mice suggests chronic treatment patients selective inhibitors cox- undermine protection cardiovascular disease premenopausal females 
